Synthesis and biological evaluation of 2-quinolineacrylamides

Synthesis and biological evaluation of 2-quinolineacrylamides Design, synthesis and preliminary bioactivity evaluations of substituted quinoline hydroxamic acid derivatives as novel histone deacetylase (HDAC) inhibitors Design, synthesis and biological evaluation of isoquinoline-based derivatives as novel histone deacetylase inhibitors Design, synthesis and biological evaluation of quinoline derivatives as HDAC class I inhibitors Potent Histone Deacetylase Inhibitors Derived from 4-(Aminomethyl)-N-hydroxybenzamide with High Selectivity for the HDAC6 Isoform Design, synthesis and biological evaluation of novel hydroxamic acid based histone deacetylase 6 selective inhibitors bearing phenylpyrazol scaffold as surface recognition motif Development of N -hydroxycinnamamide-based HDAC inhibitors with improved HDAC inhibitory activity and in vitro antitumor activity Phenylalanine-containing hydroxamic acids as selective inhibitors of class IIb histone deacetylases (HDACs) (N-Hydroxycarbonylbenylamino)quinolines as Selective Histone Deacetylase 6 Inhibitors Suppress Growth of Multiple Myeloma in Vitro and in Vivo Quinazolin-4-one Derivatives as Selective Histone Deacetylase-6 Inhibitors for the Treatment of Alzheimer’s Disease